Real-time enrollment status for this sjögren´s disease clinical trial
Current Status
Recruiting
Checked: October 3, 2026 at 11:08 PM UTC
| NCT Number | NCT07621809 |
| Recruiting Status | Recruiting |
| Condition | Sjögren´s Disease |
| Phase | PHASE3 |
| Target Enrollment | 570 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | September 28, 2026 (5 days ago) |
As of October 3, 2026: Clinical trial NCT07621809 is currently recruiting participants. This phase3 study for sjögren´s disease is actively seeking new participants at 18 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07621809 is actively recruiting participants as of October 3, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07621809 was last updated 5 days ago (September 28, 2026). HelloStudys verifies this status automatically.